Xencor, Inc. (NASDAQ:XNCR) Q4 2023 Earnings Call Transcript
Operator: Good afternoon, and thank you for standing by. Welcome to Xencor's Fourth Quarter and Year End 2023 Conference Call. At this time, all participants are in a listen-only mode.
Xencor Inc (XNCR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | EcoR1 Capital Oleg Nodelman | 5,330,416 | $107,194,666 | 3.66% | |
| 2. | Point72 Asset Management Steve Cohen | 3,120,229 | $62,747,805 | +148% | 0.15% |
| 3. | Millennium Management Israel Englander | 1,414,296 | $28,441,493 | +73% | 0.01% |
| 4. | Biotechnology Value Fund / BVF Inc Mark Lampert | 850,000 | $17,093,500 | 0.5% | |
| 5. | Woodline Partners Michael Rockefeller And Karl Kroeker | 843,325 | $16,959,266 | 0.14% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.12 | 53 | Director | 5,060 | 2024-02-13 | Filing | |
| $29.87 | 12,641 | Large Shareholder | 5,090,000 | 2019-06-06 | Filing | |
| $29.87 | 14,611 | Large Shareholder | 5,077,359 | 2019-05-02 | Filing | |
| $29.77 | 3,500 | Large Shareholder | 5,062,748 | 2019-03-25 | Filing | |
| $29.96 | 2,000 | Large Shareholder | 5,059,248 | 2019-03-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.02 | 3,366 | Officer, Director | 352,615 | 2024-11-13 | Filing | |
| $23.48 | 68,684 | Officer | 200,104 | 2024-11-11 | Filing | |
| $20.68 | 2,503 | Director | 8,490 | 2024-09-27 | Filing | |
| $20.68 | 2,503 | Director | 8,490 | 2024-09-27 | Filing | |
| $20.68 | 2,503 | Director | 9,490 | 2024-09-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,323,310 | $240,393,872 | 0% | |
| 2. | 8,901,607 | $188,981,117 | 0.14% | |
| 3. | 6,767,249 | $143,668,696 | 0% | |
| 4. | 3,326,856 | $70,629,153 | 0% | |
| 5. | 2,562,905 | $54,410,482 | 0% |
News See All
Xencor, Inc. (NASDAQ:XNCR) Q3 2023 Earnings Call Transcript
Operator: Good afternoon and thank you for standing by. Welcome to Xencor’s Third Quarter 2023 Conference Call. Please be advised that this call is going to be recorded at the company’s request.
Xencor, Inc. (NASDAQ:XNCR) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, and thank you for standing by. Welcome to Xencor's Second Quarter 2023 Conference Call. After the speakers' presentation there will be a question-and-answer session.
Xencor, Inc. (NASDAQ:XNCR) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and thank you for standing by. Welcome to Xencor's First Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.
Xencor, Inc. (NASDAQ:XNCR) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, thank you for standing by. And welcome to the Xencor's Fourth Quarter and Year End 2022 Conference Call. At this time, all participants are in a listen-only mode.
12 Best Small-Cap Healthcare Stocks To Buy Now
Macroeconomic headwinds and recessionary concerns will not weaken healthcare deals next year after the market experienced resilient mergers and acquisitions in 2022.
Were Hedge Funds Right About Xencor Inc (XNCR)?
In this article we will take a look at whether hedge funds think Xencor Inc (NASDAQ:XNCR) is a good investment right now.
Is XNCR A Good Stock To Buy Now?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September...
Xencor Inc (XNCR): Hedge Funds Are Snapping Up
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).